Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase 3 1

Status

Completed 5

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Tumor-Agnostic 1Lymphoid 1

Conditions

Neoplasms 4Cancer Pain 2Pain 1Osteoarthritis 1Lymphoma, Follicular 1Back Pain 1

Interventions

Paclitaxel 337pembrolizumab 332Carboplatin 330Cisplatin 277Gemcitabine 264Docetaxel 251Bevacizumab 239Nivolumab 230Pemetrexed 211Rituximab 183Dexamethasone 183Cyclophosphamide 169Capecitabine 169Trastuzumab 149Fluorouracil 147Ipilimumab 121atezolizumab 118Prednisone 117Erlotinib Hydrochloride 116Oxaliplatin 109Cetuximab 104Sunitinib 101Leucovorin 97Doxorubicin 97Lenalidomide 93Irinotecan 89130-nm albumin-bound paclitaxel 84durvalumab 77Bortezomib 77Azacitidine 73

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Has results × Naloxone × Clear all
NCT01885182 2019-10-04

Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 3 Completed
232 enrolled 16 charts

Neoplasms, Pain

NCT01313780 2017-12-22

TOP

Mundipharma Korea Ltd

Phase 4 Completed
128 enrolled 8 charts

Cancer Pain, Neoplasms

NCT01675531 2016-12-16

A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Mundipharma Korea Ltd

Phase 4 Completed
73 enrolled 11 charts
Tumor-Agnostic

Neoplasms

NCT01719757 2016-08-19

PROBE

Mundipharma Korea Ltd

Phase 4 Completed
359 enrolled 10 charts

Cancer Pain, Neoplasms

NCT00784810 2011-11-02

A Study to Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis

Napp Pharmaceuticals Limited

Phase 4 Completed
247 enrolled 9 charts
Lymphoid

Back Pain, Lymphoma, Follicular, Osteoarthritis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡